INTERNATIONAL PATENT: UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY, 연세대학교 산학협력단 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION FOR TREATING LYMPHOMA COMPRISING BCL-2 INHIBITOR, SELECTIVE NUCLEAR EXPORT PROTEIN INHIBITOR AND ELF4A INHIBITOR"

GENEVA, April 7 -- UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (50, Yonsei-roSeodaemun-guSeoul 03722), 연세대학교 산학협력단 (서울특별시서대문구연세로 50) filed a patent application (PCT/KR2024/014662) for "PHARMACEUTICAL COMPOSITION FOR TREATING LYMPHOMA COMPRISING BCL-2 INHIBITOR, SELECTIVE NUCLEAR EXPORT PROTEIN INHIBITOR, AND ELF4A INHIBITOR" on Sep 26, 2024. With publication no. WO/2025/071306, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...